Samsung Medical Center: Pancreatic Neoplasms trials
The registry lists 11 Pancreatic Neoplasms studies with Samsung Medical Center as lead sponsor. 4 are open to participants now and 0 have results posted.
Phase 1 1Phase 2 2No phase 8(a study in two phases counts in both)
Studies
Open to participants first, then studies with results posted, then the rest; newest registration first within each.
- PULSAR in Systemic Therapy for Pancreatic CancerRecruitingNCT07269626Phase 2
- Development of a Prediction Platform for Neoadjuvant Treatment and Prognosis in Pancreatic Cancer Using OrganoidNot yet recruitingNCT04777604
- Development of a Prediction Platform for Adjuvant Treatment and Prognosis in Resected Pancreatic Cancer Using OrganoidRecruitingNCT04736043
- The Relationship Between Triceps Skinfold and Overall Survival of Pancreas, Bile Duct, Gallbladder CancerRecruitingNCT03637569
- Vactosertib With Nal-IRI/FL in Metastatic Pancreatic Ductal Adenocarcinoma.Status unknownNCT04258072Phase 1
- Circulating Cell-free Tumor DNA(ctDNA) in Pancreatic CancerStatus unknownNCT02934984
- Randomized, Controlled Trial of Endoscopic Ultrasound-Guided Bilateral Celiac Plexus Neurolysis vs Celiac Ganglia Neurolysis to Control Pain in Inoperable Pancreatic Cancer Patients With Inadequate Pain Control by Pain KillerStatus unknownNCT02220062Not applicable
- Comparing Newly Developed PreCore Needle With Conventional Fine Needle in Suspected Unresectable Pancreatic CancerCompletedNCT01876069Not applicable
- Comparative Study of 22 and 25 Gauge ProCore EUS-guided Biopsy in Pancreatic MassCompletedNCT01727921Not applicable
- Prospective Study Comparing Methods of Obtainment of Specimen After EUS-FNA in Patients With Peri-pancreatic MassCompletedNCT01354795Not applicable
- Trial of Simvastatin and Gemcitabine in Pancreatic Cancer PatientsCompletedNCT00944463Phase 2